Sousa Da Silva Richard X, Weber Achim, Dutkowski Philipp, Clavien Pierre-Alain
Department of Surgery and Transplantation, Swiss Hepato-Pancreato-Biliary and Transplant Center, University Hospital Zurich, Zurich, Switzerland.
Wyss Zurich Translational Center, Swiss Federal Institute of Technology ETH Zurich/University of Zurich, Zurich, Switzerland.
Hepatology. 2022 Nov;76(5):1531-1549. doi: 10.1002/hep.32546. Epub 2022 May 17.
Although liver transplantation is a true success story, many patients still die awaiting an organ. The increasing need for liver grafts therefore remains an unsolved challenge to the transplant community. To address this, transplant donor criteria have been expanded and, for example, more liver grafts with significant steatosis or from donors with circulatory death are being used. These marginal grafts, however, carry an increased risk of graft-associated complications, such as primary nonfunction, delayed graft function, or late biliary injuries. Therefore, reliable assessment of graft viability before use is essential for further success. To achieve this, machine liver perfusion, a procedure developed more than 50 years ago but almost forgotten at the end of the last century, is again of great interest. We describe in this review the clinical most applied machine perfusion techniques, their mechanistic background, and a novel concept of combining immediate organ assessment during hypothermic oxygenated perfusion, followed by an extended phase of normothermic machine perfusion, with simultaneous ex situ treatment of the perfused liver. Such a new approach may allow the pool of usable livers to dramatically increase and improve outcomes for recipients.
尽管肝移植是一个真正的成功案例,但仍有许多患者在等待器官移植的过程中死亡。因此,对肝移植供体的需求不断增加,这仍然是移植界尚未解决的挑战。为了解决这个问题,移植供体标准已经扩大,例如,更多有明显脂肪变性的肝移植供体或来自循环死亡供体的肝移植供体正在被使用。然而,这些边缘性移植物发生移植物相关并发症的风险增加,如原发性无功能、移植功能延迟或晚期胆管损伤。因此,在使用前对移植物活力进行可靠评估对于进一步取得成功至关重要。为了实现这一点,机器肝脏灌注这一在50多年前就已开发但在上世纪末几乎被遗忘的技术,再次引起了人们的极大兴趣。在这篇综述中,我们描述了临床上最常用的机器灌注技术、它们的作用机制背景,以及一个新的概念,即在低温氧合灌注期间进行即时器官评估,随后进入常温机器灌注的延长阶段,并同时对灌注的肝脏进行体外处理。这样一种新方法可能会使可用肝脏的数量大幅增加,并改善受者的预后。